Pharma Pulse 3/27/25: Ethical Considerations for AI Use in Medication Access, The Future of PBMs in 2025 & more

Ethical Considerations for AI Use in Medication Access

Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, discusses ethical considerations surrounding AI use in medication access and how the industry can ensure that these technologies are used responsibly and equitably.

The Future of PBMs in 2025: AI, Regulations, and Transparency Initiatives

Pharmacy benefit managers play a critical role in the US health care system by managing prescription drug benefits for insurers, government programs, and employers. However, the industry faces growing scrutiny over pricing transparency, rebate structures, and patient access to medications. As we move into 2025, the PBM landscape is undergoing significant transformation driven by regulatory changes, artificial intelligence integration, and transparency initiatives.

Europe Rapidly Falling Behind China in Pharma, AstraZeneca CEO Warns

Europe is fast losing its edge to China in pharmaceutical innovation, AstraZeneca Plc Chief Executive Officer Pascal Soriot warned.

Four New Studies Demonstrate that Viz.ai Finds New Patients with Hypertrophic Cardiomyopathy Earlier When Embedded into the Clinical Workflow

Viz.ai announced new clinical data demonstrating how the Viz HCM module enables faster, accurate detection of signs of hypertrophic cardiomyopathy (HCM) to help ensure that more patients receive the care they need. Four studies, which will be presented at the American College of Cardiology’s Annual Scientific Session & Expo 2025, show the real-world impact of Viz.ai in clinical practice with earlier detection and triaging of new patients with HCM, a commonly inherited heart disease that often goes undetected.

Sydney Buell, MBA on LinkedIn

I had the pleasure of attending Pharma USA this week alongside my incredible colleague Cathy Williams!

It was an amazing opportunity to connect with industry leaders, exchange insights, and stay ahead of the latest trends shaping the pharmaceutical world. From thought-provoking presentations to valuable networking, we left with a wealth of knowledge and fresh perspectives that will continue to drive Pharmaceutical Executive and Pharmaceutical Commerce forward.

#REpharmaUSA

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs